Avon Foundation Program to Improve Quality of Life in Breast Cancer Survivors

Not Applicable

Completed

• Conditions: Breast Cancer
• Interventions: Behavioral: Mindfulness based meditation program

• Registration Number: NCT00278837
• Lead Sponsor: Weill Medical College of Cornell University

Brief Summary

Women with breast cancer often suffer significant distress and disability from their disease. A practice of meditation-based stress reduction and cognitive-affective-behavioral learning may help women with breast cancer decrease their suffering and improve their quality of life.

Detailed Description

The objective of this study in women recently treated for breast cancer is to determine whether an intervention program consisting of group and individual instruction in a meditation-based practice of stress-reduction and cognitive-affective-behavioral learning has the potential for reducing disabling distress and improving quality of life in a population vulnerable to the progression or recurrence of disease. Quality of life will be assessed at 12 months.

Study Timeline

• Study Start: 2003-05
• Study First Submitted: 2006-01-13
• Study First Submitted QC: 2006-01-13
• Study First Posted: 2006-01-18
• Primary Completion: 2010-03
• Study Completion: 2010-03
• Status Verified: 2017-02
• Last Update Submitted: 2017-02-17
• Last Update Posted: 2017-02-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 94

Inclusion Criteria

All women with stage I-III breast cancer who have received treatment within the preceding year will be eligible for inclusion in the study.

Exclusion Criteria

1. Patients who refuse to participate will be excluded
2. Patients with metastatic (stage IV) cancer are excluded.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Mindfulness based meditation program	Mindfulness based meditation program	Meditation and Breast Cancer: Subjects will participate in an intervention consisting of group and individual instruction in a meditation-based practice of stress reduction and cognitive-affective-behavioral learning.

Primary Outcome Measures

Name	Time	Method
Quality of life will be assessed by within patient differences in the FACT-G (General Functional Assessment of Cancer Treatment Scale), as well as with the disease specific subscales at baseline and at 12 months.	Subjects will complete questionnaires at baseline and closeout. Patients will participate in the meditation program weekly for 20 weeks.

Trial Locations

Locations (1)

The New York Presbyterian Hospital-Weill Medical Center; 🇺🇸 New York, New York, United States